#pharmanews — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #pharmanews, aggregated by home.social.
-
5 neuro data readouts to watch in the second half of 2024 — GSK moves to new HQ in return to central London — AbbVie led the way in paying doctors to pitch its drugs last year —http://bit.ly/w28kSd #clinicaltrials #neurology #gsk #london #abbvie #physicians #physicianpayments #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Coherus, Junshi’s PD-1 blocker Loqtorzi aces phase III liver cancer trial—Supreme Court preserves access to abortion pill mifepristone —Pfizer gene therapy for Duchenne fails to meet goals of key trial—http://bit.ly/w28kSd #surpremecourt #livercancer #pfizer #dmd #genetherapy #abortionpill #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Gilead pays $4.3B for CymaBay, primarily for liver disease med—Pharma showed up for the big game — CSL’s ‘big’ post-heart attack drug fails in Phase III trial--http://bit.ly/w28kSd #gileadsciences #mergersandacquisitions #liverdisease #heartattack #clinicaltrials #superbowl #pharmaadvertising #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
J&J opens the valve on $50M MS partnership with Pipeline — The end of an era: Regeneron chairman Roy Vagelos to retire after 29-year run— Merck to buy inflammatory disease drugmaker Prometheus for $10.8B -- See more on our front page news http://bit.ly/w28kSd #JNJ #ms #multiplesclerosis #chairman #regeneron #merck #inflammatorydisease #mergersandacquisitions #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma